The different faces of echocardiographic left ventricular hypertrophy: clues to the etiology

Frank Weidemann1, Markus Niemann, Georg Ertl

  • 1Department of Internal Medicine I/Center of Cardiovascular Disease, University of Würzburg, Würzburg, Germany. weidemann_f@medizin.uni-wuerzburg.de

Insights

Left ventricular hypertrophy (LVH) has varied causes and appearances. Echocardiography can identify specific LVH patterns to aid in diagnosing underlying conditions early.

Area of Science:

  • Cardiology
  • Cardiac Imaging
  • Diagnostic Medicine

Background:

  • Left ventricular hypertrophy (LVH) is a common cardiac response to diverse stimuli, including exercise and various diseases.
  • LVH is not uniform; its morphologic and functional characteristics vary based on the underlying cause.
  • Accurate characterization of LVH is crucial for timely diagnosis of associated conditions.

Purpose of the Study:

  • To systematically review echocardiographic patterns associated with different types of cardiac hypertrophy.
  • To guide clinicians in interpreting echocardiographic findings for early diagnosis of underlying cardiac conditions.
  • To address the lack of comprehensive guidance on approaching LVH in clinical practice.

Main Methods:

  • Systematic review of established and advanced echocardiographic imaging modalities.
  • Analysis of typical echocardiographic patterns for important types of cardiac hypertrophy.
  • Focus on morphologic and functional characteristics relevant to diagnosis.

Main Results:

  • Echocardiography reveals distinct patterns of LVH depending on the underlying pathologic mechanism.
  • Specific imaging features correlate with different etiologies of cardiac hypertrophy.
  • The review provides a framework for interpreting these patterns.

Conclusions:

  • Echocardiography is the clinical reference standard for assessing LVH.
  • Recognizing specific echocardiographic patterns of LVH facilitates the diagnosis of underlying cardiac and systemic diseases.
  • This systematic approach enhances diagnostic accuracy and timely intervention.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Imaging Studies for Cardiovascular System II:Types of Echocardiography01:20

Imaging Studies for Cardiovascular System II:Types of Echocardiography

Echocardiography plays a role in assessing cardiac health and detecting heart conditions, with various types providing critical insights for diagnosis and treatment.
Types of Echocardiography
Transthoracic Echocardiography (TTE)
TTE is the most common type of echocardiogram which involves placing a transducer on the patient's chest, emitting sound waves to create heart images. TTE is invaluable for evaluating the heart's size, structure, and motion, making it particularly useful for diagnosing...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...